Today: October 05, 2024
Today: October 05, 2024

Latest From Reuters

Health|Science

US FDA declines to approve Rocket Pharma's immune disorder gene therapy

Rocket Pharmaceuticals said on Friday the U.S. health regulator declined to approve its gene therapy to treat a rare and severe pediatric disorder that causes the immune

US FDA declines to approve Rocket Pharma's immune disorder gene therapy
Environment|Science

Beryl sets tone for 'very dangerous hurricane season,' world meteorological agency says

Hurricane Beryl, which has strengthened to a Category 5 storm, is setting the tone for a

Beryl sets tone for 'very dangerous hurricane season,' world meteorological agency says
Science|Technology

Russia plans to create core of new space station by 2030

Russia is aiming to create the four-module core of its planned new orbital space station by 2030, its Roscosmos space agency said on Tuesday.

Russia plans to create core of new space station by 2030
Science|Technology

Boeing Starliner's helium leak adds another delay to debut crew flight

NASA again delayed Boeing's debut crewed flight of its Starliner capsule on Tuesday so engineers can spend more time evaluating a helium leak in the spacecraft's propulsion system, the

Boeing Starliner's helium leak adds another delay to debut crew flight
Science|Technology

Boeing, NASA target June 5 for Starliner's debut crew flight

Boeing and NASA said on Sunday that their teams are preparing to launch the new Starliner space capsule on June 5 after scrubbing its inaugural test flight launch attempt on Saturday.

Boeing, NASA target June 5 for Starliner's debut crew flight
Science|Technology

SERA names India as partner country for Blue Origin space flight

The U.S.-based Space Exploration and Research Agency (SERA) on Monday announced India as a partner country in its human spaceflight programme, which will see six citizen

SERA names India as partner country for Blue Origin space flight
Health|Science

Japan's Eisai developing dementia drug for US market, Nikkei reports

Japanese drugmaker Eisai is developing a dementia treatment that it aims to commercialise in the U.S. by fiscal 2030, the Nikkei reported on Sunday.

Japan's Eisai developing dementia drug for US market, Nikkei reports
Health|Science

Gilead's long-acting HIV drug superior to daily pill Truvada in study

Gilead Sciences said on Thursday a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing

Gilead's long-acting HIV drug superior to daily pill Truvada in study
Environment|Science

Fossils of ancient crocodile-like reptile found in Brazil

A Brazilian scientist has identified fossils of a small crocodile-like reptile that lived during the Triassic Period several million years before the first dinosaurs.

Fossils of ancient crocodile-like reptile found in Brazil
Environment|Science|Technology

Solar can provide 20% of world electricity on northern summer solstice, thinktank says

The world has enough solar power capacity to generate a fifth of its midday peak electricity needs on the longest day of the year in the northern hemisphere, up from 16% last year,

Solar can provide 20% of world electricity on northern summer solstice, thinktank says
Business|Health|Science

Roche partners with Ascidian Therapeutics to develop gene therapies

Swiss drugmaker Roche will team up with privately held biotech Ascidian Therapeutics to develop gene therapies targeting difficult to treat neurological diseases, the Boston-based startup

Roche partners with Ascidian Therapeutics to develop gene therapies
Business|Environment|Science|Technology

Germany's solar installations up 35% in early 2024

Germany's solar power installation rose by 35% year-on-year in the first four months of 2024, boosted by a rise in industrial, commercial and ground-mounted photovoltaics demand,

Germany's solar installations up 35% in early 2024
Health|Science

AstraZeneca's breast cancer drug combination fails in late-stage trial

AstraZeneca said on Tuesday its breast cancer drug, Truqap, in combination with chemotherapy agent, paclitaxel, did not meet its main goals in a late-stage trial to improve overall

AstraZeneca's breast cancer drug combination fails in late-stage trial
Health|Science

Moderna says its RSV shot is 50% effective across a second season

Moderna Inc respiratory syncytial virus (RSV) shot mRESVIA showed 50% efficacy in preventing RSV after 18 months, the drugmaker said on Wednesday.

Moderna says its RSV shot is 50% effective across a second season
Health|Science

US FDA recommends steps to improve diversity in clinical trials

The U.S. Food and Drug Administration on Wednesday recommended steps for drugmakers and medical device makers to improve racial, ethnic and other diversity in their clinical trials.

US FDA recommends steps to improve diversity in clinical trials
Environment|Science

Argentina sequences leafhopper genome to battle crop-destroying insect

An Argentine scientific institute has cracked the genome of the leafhopper, the insect which carries the bacteria responsible for wiping out vast swathes of the South American

Argentina sequences leafhopper genome to battle crop-destroying insect
Economy|Environment|Science|Technology

Data centers, EVs to significantly boost US power load by 2030, consultancy says

Data centers and electric vehicles are expected to ramp up U.S. power demand by about 300 terawatt-hours (TWh), equivalent to the electricity consumed annually by Turkey, by the

Data centers, EVs to significantly boost US power load by 2030, consultancy says
Health|Science|Technology

Lilly partners with OpenAI to develop medicines for drug-resistant bacteria

Eli Lilly said on Tuesday it will collaborate with OpenAI to leverage its generative AI to develop antimicrobials that can be used to treat drug-resistant bacteria.

Lilly partners with OpenAI to develop medicines for drug-resistant bacteria
Health|Science

AstraZeneca's Imfinzi fails in late-stage trial to treat certain lung cancers

AstraZeneca's blockbuster cancer drug Imfinzi has failed as a follow-up therapy to improve disease-free survival in a late-stage trial in patients with a type of early-stage lung cancer,

AstraZeneca's Imfinzi fails in late-stage trial to treat certain lung cancers
Environment|Science

Over 200 howler monkeys in Mexico perish in heatwave, says NGO

At least 234 threatened howler monkeys have died in tropical forests in the south-eastern Mexican state of Tabasco, wildlife non-profit Cobius said on Monday, a figure nearly

Over 200 howler monkeys in Mexico perish in heatwave, says NGO
Business|Science|Technology

Toyota to launch first EV with advanced self driving system for China in 2025

Toyota is planning to launch the first electric car model equipped with an advanced autonomous driving system similar to Tesla's Full Self-Driving for the Chinese market next year

Toyota to launch first EV with advanced self driving system for China in 2025
Health|Science

Eisai and Biogen launch Alzheimer's drug Leqembi in China

Eisai and Biogen have launched their Alzheimer's treatment Leqembi in China, the third country after the United States and Japan, the companies said on Friday.

Eisai and Biogen launch Alzheimer's drug Leqembi in China
Science|Technology

NASA, Boeing continue evaluating Starliner's propulsion system performance

NASA said on Thursday that it would continue to evaluate Starliner's propulsion system performance along with Boeing before the shuttle returns from the International Space Station (ISS).

NASA, Boeing continue evaluating Starliner's propulsion system performance
Business|Economy|Environment|Science

Companies forging a rare earths industry in the EU

In the rare earths sector, the EU will struggle to meet most of its ambitious goals in new legislation designed to boost domestic output of critical minerals and reduce dependence

Companies forging a rare earths industry in the EU
Environment|Science

Beluga whale pair move from Ukraine's war-torn Kharkiv to Spain's Valencia

Marine biologists have moved a pair of beluga whales from the Ukrainian city of Kharkiv - the target of daily shelling by Russian forces - to the eastern Spanish city of Valencia,

Beluga whale pair move from Ukraine's war-torn Kharkiv to Spain's Valencia

Follow